Monday, November 16, 2026
Google search engine
HomeLifestyleAustralian researchers investigating brain health are studying a link between shingles vaccine...

Australian researchers investigating brain health are studying a link between shingles vaccine and lowering dementia

A vaccine used to prevent shingles could hold a clue to reducing dementia risk, sparking a debate to lower the age for free vaccines.

A new study, planned to begin in January 2027 at St Vincent’s Hospital in Sydney, follows research in Australia and overseas linking shingles vaccination to fewer dementia diagnoses.

WATCH THE ABOVE VIDEO: Shingles vaccine linked to lower dementia risk

Know the news with the 7NEWS app: Download today Arrow

Federal Health Minister Mark Butler told 7NEWS he was open to lowering the age for free vaccination if stronger evidence emerged. Shingles occurs when the virus that causes chickenpox reactivates, sometimes decades after the original infection. It can cause a painful, blistering rash and lingering nerve pain.

The vaccine helps the immune system keep the virus in check.

Most Australians qualify for a free shingles vaccine from the age of 65.

Aboriginal and Torres Strait Islander people qualify from 50, and eligible adults with weakened immune systems can qualify from 18. “We’re always open to seeing evidence that indicates there’s good clinical reason to reduce the age even further,” Butler said. “At the moment this research about impacts on dementia is still relatively early.” Asked about funding larger trials, Minister Butler pointed to the existing application process. “I’ve read it with great interest but we’d want to see it develop a little bit more first.”

What science says about lowering your dementia risk

A study in Wales estimated people who received an earlier shingles vaccine were 20 per cent less likely to be diagnosed with dementia over seven years. St Vincent’s Clinic neurologist Dr David Jakabek said one theory was the virus could affect the brain even when it did not cause shingles.

Another was that vaccination could help the immune system work better as people age. “There’s several different mechanisms that may influence the immune system and brain health,” he said. The Sydney team plans to take blood samples from adults over 60 before vaccination and track changes over eight weeks.

Be the first to know:

The study will include people with early Alzheimer’s disease and people without it. Researchers will look for changes in blood markers linked to brain inflammation and Alzheimer’s.

NSW researchers are preparing to test whether the jab changes signs of inflammation linked to brain health.
NSW researchers are preparing to test whether the jab changes signs of inflammation linked to brain health. Credit: 7NEWS

Larger trials would be needed to establish whether the vaccine can prevent or delay dementia. Ann Pietsch, a Dementia Australia advocate living with Lewy body dementia, said research offered hope to families. “Anything that can help with early diagnosis or with treatment of dementia is absolutely fabulous,” she told 7NEWS. Dementia is Australia’s leading cause of death, and risk can build in midlife, years before symptoms appear.

Source

RELATED ARTICLES
Google search engine

Most Popular

Recent Comments